Prednisolone for the first rhinovirus-induced wheezing and 4-year asthma risk: A randomized trial

Pediatric Allergy and Immunology

Volumn 28, Issue 6, 2017, Pages 557-563

  Koistinen, Annamari ^a   Lukkarinen, Minna ^a,b   Turunen, Riitta ^a   Vuorinen, Tytti ^a   Vahlberg, Tero ^c   Camargo, Carlos A ^d   Gern, James ^e   Ruuskanen, Olli ^a   Jartti, Tuomas ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

asthma; corticosteroid; prednisolone; rhinovirus; virus load; wheezing

Indexed keywords

PLACEBO; PREDNISOLONE; ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT;

ADOLESCENT; ARTICLE; ASTHMA; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE CONTROL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICATION COMPLIANCE; NASOPHARYNGEAL ASPIRATION; PATIENT COMPLIANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RHINOVIRUS; RHINOVIRUS INFECTION; TIME TO TREATMENT; TREATMENT OUTCOME; VIRUS GENOME; VIRUS LOAD; WHEEZING; ABNORMAL RESPIRATORY SOUND; COMPLICATION; DRUG ADMINISTRATION; INFANT; ORAL DRUG ADMINISTRATION; PICORNAVIRUS INFECTION; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX; VIROLOGY;

ADMINISTRATION, ORAL; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; PICORNAVIRIDAE INFECTIONS; PREDNISOLONE; PROSPECTIVE STUDIES; RESPIRATORY SOUNDS; RHINOVIRUS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VIRAL LOAD;

EID: 85026811412     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/pai.12749     Document Type: Article

References (28)

1. Jartti T, Vanto T, Heikkinen T, Ruuskanen O. Systemic glucocorticoids in childhood expiratory wheezing: relation between age and viral etiology with efficacy. Pediatr Infect Dis J. 2002;21:873-878.
2. Oommen A, Lambert PC, Grigg J. Efficacy of a short course of parent-initiated oral prednisolone for viral wheeze in children aged 1-5 years: randomised controlled trial. Lancet. 2003;362:1433-1438.
3. Panickar J, Lakhanpaul M, Lambert PC, et al. Oral prednisolone for preschool children with acute virus-induced wheezing. N Engl J Med. 2009;360:329-338.
4. de Benedictis FM, Bush A. Corticosteroids in respiratory diseases in children. Am J Respir Crit Care Med. 2012;185:12-23.
5. Dumas O, Mansbach JM, Jartti T, et al. A clustering approach to identify severe bronchiolitis profiles in children. Thorax. 2016;71:712.
6. Midulla F, Nicolai A, Ferrara M, et al. Recurrent wheezing 36 months after bronchiolitis is associated with rhinovirus infections and blood eosinophilia. Acta Paediatr. 2014;103:1094-1099.
7. Rubner FJ, Jackson DJ, Evans MD, et al. Early life rhinovirus wheezing, allergic sensitization, and asthma risk at adolescence. J Allergy Clin Immunol. 2017;139:501-507.
8. Lukkarinen M, Lukkarinen H, Lehtinen P, et al. Prednisolone reduces recurrent wheezing after first rhinovirus wheeze: a 7-year follow-up. Pediatr Allergy Immunol. 2013;24:237-243.
9. Jartti T, Nieminen R, Vuorinen T, et al. Short- and long-term efficacy of prednisolone for first acute rhinovirus-induced wheezing episode. J Allergy Clin Immunol. 2015;135:691-698.
10. National Heart Lung and Blood Institute. Expert panel report 3: Guidelines for the diagnosis and management of asthma - Full report; 2007. http://www.nhlbi.nih.gov/health-pro/guidelines/current/asthma-guidelines. Accessed August 28, 2007.
11. Working group set up by the Finnish Medical Society Duodecim and the Finnish Cardiac Society, Helsinki. Current Care Guidelines: Asthma; 2012. www.kaypahoito.fi. Accessed September 24, 2012.
12. Turunen R, Koistinen A, Vuorinen T, et al. The first wheezing episode: respiratory virus etiology, atopic characteristics, and illness severity. Pediatr Allergy Immunol. 2014;25:796-803.
13. Söderlund-Venermo M, Lahtinen A, Jartti T, et al. Clinical assessment and improved diagnosis of bocavirus-induced wheezing in children, Finland. Emerg Infect Dis. 2009;15:1423-1430.
14. Jartti T, Lehtinen P, Vuorinen T, Ruuskanen O. Bronchiolitis: age and previous wheezing episodes are linked to viral etiology and atopic characteristics. Pediatr Infect Dis J. 2009;28:311-317.
15. Jakiela B, Brockman-Schneider R, Amineva S, Lee WM, Gern JE. Basal cells of differentiated bronchial epithelium are more susceptible to rhinovirus infection. Am J Respir Cell Mol Biol. 2008;38:517-523.
16. Takeyama A, Hashimoto K, Sato M, et al. Rhinovirus load and disease severity in children with lower respiratory tract infections. J Med Virol. 2012;84:1135-1142.
17. Esposito S, Daleno C, Scala A, et al. Impact of rhinovirus nasopharyngeal viral load and viremia on severity of respiratory infections in children. Eur J Clin Microbiol Infect Dis. 2014;33:41-48.
18. Xiao Q, Zheng S, Zhou L, et al. Impact of human rhinovirus types and viral load on the severity of illness in hospitalized children With lower respiratory tract infections. Pediatr Infect Dis J. 2015;34:1187-1192.
19. Bruning AH, Thomas XV, van der Linden L, et al. Clinical, virological and epidemiological characteristics of rhinovirus infections in early childhood: a comparison between non-hospitalised and hospitalised children. J Clin Virol. 2015;73:120-126.
20. Baraldo S, Contoli M, Bazzan E, et al. Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma. J Allergy Clin Immunol. 2012;130:1307-1314.
21. Contoli M, Ito K, Padovani A, et al. Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells. Allergy. 2015;70:910-920.
22. Stone CA Jr, Miller EK. Understanding the association of human rhinovirus with asthma. Clin Vaccine Immunol. 2015;23:6-10.
23. Stellato C. Glucocorticoid actions on airway epithelial responses in immunity: functional outcomes and molecular targets. J Allergy Clin Immunol. 2007;120:1247-1263.
24. Kennedy JL, Shaker M, McMeen V, et al. Comparison of viral load in individuals with and without asthma during infections with rhinovirus. Am J Respir Crit Care Med. 2014;189:532-539.
25. Miller EK, Hernandez JZ, Wimmenauer V, et al. A mechanistic role for type III IFN-λ1 in asthma exacerbations mediated by human rhinoviruses. Am J Respir Crit Care Med. 2012;185:508-516.
26. Jartti T, Hasegawa K, Mansbach JM, Piedra PA, Camargo CA Jr. Rhinovirus-induced bronchiolitis: lack of association between virus genomic load and short-term outcomes. J Allergy Clin Immunol. 2015;136:509-512.
27. Bønnelykke K, Vissing NH, Sevelsted A, Johnston SL, Bisgaard H. Association between respiratory infections in early life and later asthma is independent of virus type. J Allergy Clin Immunol. 2015;136:81-86.
28. Lukkarinen M, Vuorinen T, Lehtinen P, Ruuskanen O, Jartti T. Sensitization at the first wheezing episode increases risk for long-term asthma therapy. Pediatr Allergy Immunol. 2015;26:687-691.